Intermittent fasting (IF) that limits eating times was found to reduce chronic pain and improve cognition that had declined due to pain in animal experiments.
The researchers identified a new pathway in which alterations of the gut microbiota affect brain inflammatory responses.
The study was conducted jointly by the First Affiliated Hospital of Zhengzhou University in China and Chiba University in Japan. Rats with experimentally induced chronic pain were subjected to IF consisting of 24 hours without food followed by 24 hours of free feeding, repeated for 38 days.
After the 38‑day regimen, the investigators observed reductions in pain behaviors and improvements in cognitive performance, suggesting that IF may modulate pain‑related brain inflammation via gut microbiota changes.
Research & ReportsSep 6, 2026•1 min read
Intermittent Fasting Reduces Chronic Pain and Improves Cognition in Rat Study
Animal experiments show time‑restricted feeding lowers chronic pain and restores pain‑related cognitive deficits, linked to gut microbiota‑driven brain inflammation.
Compiled by the PharmaCountry team · Source: KPA News
Ratings
(0)
(0)
(0)
(0)
(0)
More articles
View all insightsResearch & Reports
Global Finished Dosage Manufacturing Landscape 2026
Oct 5, 2026
Regulatory UpdatesKorea Korus hit with 1‑month manufacturing suspension over missing post‑marketing safety test
Sep 28, 2026
AnalysisPharma distributors set delivery cut‑offs ahead of Chuseok holiday (Sep 21‑23)
Sep 28, 2026
Leave your rating